20. CLINICAL AND SUBCLINICAL FEATURES OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFD) IN PATIENT WITH TYPE 2 DIABETES MELLITUS IN NGHE AN FRIENDSHIP GENERAL HOSPITAL 2023
Main Article Content
Abstract
Objectives: To investigate non-alcoholic fatty liver disease’s clinical and subclinical characteristics in patients with type 2 diabetes from July 2022 to June 2023.
Population and methods: Case series description of 262 patients who had type 2 diabetes with nonalcoholic fatty liver disease. Diagnosis of fatty liver by ultrasound.
Results: Average age 66.5 ± 10.7; the ratio of men and women is 49.2% and 50.8%. Typical clinical symptoms are fatigue and loss of appetite (99.6% and 96.6%). Common paraclinical indicators include decreased red blood cell count, decreased hemoglobin, increased LDL-C, and increased HDL-C in 34.4%, 75.9%, 71.0%, and 38.9%, respectively. Hemoglobin count, platelet count, and LDL-C index in women were higher than in men, with p<0.05. The degree of fatty liver on ultrasound is mainly
Conclusion: Non-alcoholic fatty liver disease in patients with type 2 diabetes has unclear clinical features, and subclinical characteristics differ between men and women.
Article Details
Keywords
Non-alcoholic fatty liver disease; type 2 diabetes; Nghe An genaral Friendship Hospital.
References
Disease, an Overview. Integr Med (Encinitas),
18(2), 2019,42-49.
[2] Quentin MA, Helen LR, Elena K et al., From
NASH to HCC: current concepts and future
challenges, Nat Rev Gastroenterol Hepatol,
16(7), 2019, 411-428.
[3] Byung Wan Lee YHL, Cheol YP et al.,
NonAlcoholic Fatty Liver Disease in Patients with
Type 2 Diabetes Mellitus: A Position Statement
of the Fatty Liver Research Group of the Korean
Diabetes Association, Diabetes Metab J, 44(3),
2020, 382-401.
[4] Singal AK, Anand BS, Recent Trends in the
Epidemiology of Alcoholic Liver Disease,
Clinical Liver Disease, 2(2), 2013, 53-56.
[5] Trần Thị Khánh Tường, Yếu tố nguy cơ dự đoán
xơ hóa gan tiến triển trên bệnh nhân đái tháo
đường type 2 bị bệnh gan nhiễm mỡ không do
rượu, Tạp chí Y dược lâm sàng 108, 15(4), 2020,
67-72.
[6] Chongyang Ma KY, Zisong W et al., The
association between hypertension and
nonalcoholic fatty liver disease (NAFLD):
literature evidence and systems biology analysis,
Bioengineered, 12(1), 2021, 2187-2202.159
[7] Phan Diễm Quỳnh, Đỗ Trung Quân, Nhận xét
tình trạng đề kháng insulin trên bệnh nhân gan
nhiễm mỡ, Tạp chí nội tiết Đái tháo đường, 41,
2020, 106-117.
[8] O Akha, al HFe. Evaluation of the Correlation
between Non-Alcoholic Fatty Liver Disease and
Insulin Resistance, Iranian Red Crescent Medical
Journal, 12(3), 2010, 282-286.
[9] Ferraioli G, Soares Monteiro LB, Ultrasoundbased
techniques for the diagnosis of liver steatosis.
World J Gastroenterol; 25(40), 2019,6053-6062.
[10] Muzica CM, Sfarti C, Trifan A et al.,
Nonalcoholic Fatty Liver Disease and Type 2
Diabetes Mellitus: A Bidirectional Relationship,
Can J Gastroenterol Hepatol, 2020:6638306.